Results 301 to 310 of about 190,067 (321)
Some of the next articles are maybe not open access.
Abberrant Muscular Insertions in Crouzon's Disease
Journal of Pediatric Ophthalmology & Strabismus, 1980Herein we present a case of Crouzon's disease with anomalous medial rectus formation and horizontal recti insertions. This adds a feature of the disease to the literature and reminds us to approach strabismus in orbital anomalies cautiously via a limbal peritomy.
Robert W Lingua, Anthony R Captuo
openaire +3 more sources
Proteolysis of β-dystroglycan in muscular diseases
Neuromuscular Disorders, 2005Alpha-dystroglycan is a cell surface peripheral membrane protein which binds to the extracellular matrix (ECM), while beta-dystroglycan is a type I integral membrane protein which anchors alpha-dystroglycan to the cell membrane via the N-terminal extracellular domain.
Teruo Shimizu+8 more
openaire +3 more sources
Using immunoglobulins in muscular disease treatment
Expert Opinion on Biological Therapy, 2008Intravenous immunoglobulins (IVIg) have been proven in the past two decades to be potent immunomodulators. This led to the licensing and recommendation of IVIg as first-line treatment for Kawasaki disease, idiopathic thrombocytopenic purpura and Guillain-Barré syndrome.To review the evidence and indications for the use of IVIg in the treatment of ...
Refik Pul, Martin Stangel
openaire +3 more sources
Chemical Laboratory Studies in Muscular Disease
Postgraduate Medicine, 1967Although studies have been made of the relationship of numerous enzymes to diagnosis of muscular disease, only those concerning aldolase, glutamic-oxalacetic transaminase, lactic dehydrogenase and creatine phosphokinase have been of real value. Because the increase in serum activity of these enzymes fluctuates, it is necessary to study them on several ...
openaire +3 more sources
Duchenne muscular dystrophy—Meryon's disease
Neuromuscular Disorders, 1993In a communication to the Royal Medical and Chirurgical Society of London in December 1851, which was published in the Transactions of the Society the following year, Edward Meryon, an English physician, described, in considerable detail, eight boys in three families with a disease later referred to as Duchenne muscular dystrophy.
openaire +3 more sources
Archives of Neurology, 2004
X-linked bulbar and spinal muscular atrophy was comprehensively described by William R. Kennedy, and later the syndrome carried his name. It was the first triplet-repeat disease to be discovered. Recent transgenic experiments have shed some light on the underlying pathogenesis.
Michael Sinnreich, Christopher J. Klein
openaire +3 more sources
X-linked bulbar and spinal muscular atrophy was comprehensively described by William R. Kennedy, and later the syndrome carried his name. It was the first triplet-repeat disease to be discovered. Recent transgenic experiments have shed some light on the underlying pathogenesis.
Michael Sinnreich, Christopher J. Klein
openaire +3 more sources
Diet and Muscular Disease in Calves
Proceedings of the British Society of Animal Production, 1953During the early stages of investigations concerned with the dietary requirement of dairy calves for certain amino-acids (Blaxter & Wood, 1952a), we had occasion to devise rations simulating milk to meet the calves’ basic requirements. These consisted of reconstituted dried skim-milk powder, glucose, trace elements, lard as a source of fat and a ...
openaire +2 more sources
Journal of the American College of Surgeons, 2003
Miguel Echenique Elizondo+1 more
openaire +3 more sources
Miguel Echenique Elizondo+1 more
openaire +3 more sources
Abnormal Hepatic Tests in Muscular Disease
A.M.A. Archives of Internal Medicine, 1959Introduction Many clinical observations relating liver function to muscle disease have not been objectively tested. 1-3 The observation that some patients with muscular disease have had episodes of jaundice suggested a study of liver functions in patients with muscular disease. Material and Methods 1. Test Selection.
openaire +2 more sources
A disease-specific therapy in facioscapulohumeral muscular dystrophy
The Lancet NeurologyContains fulltext : 307881.pdf (Publisher’s version ) (Closed access)
Voermans, N.C., Vissing, J.
openaire +3 more sources